tiprankstipranks
Advertisement
Advertisement
PremiumCompany AnnouncementsPolaryx Therapeutics Raises $10 Million to Fund SOTERIA Trial
3M ago
Polaryx receives U.S. FDA Fast Track Designation for PLX-200
Premium
The Fly
Polaryx receives U.S. FDA Fast Track Designation for PLX-200
4M ago
Polaryx’s PLX-200 granted FDA Fast Track Designation in LINCL/CLN2
Premium
The Fly
Polaryx’s PLX-200 granted FDA Fast Track Designation in LINCL/CLN2
5M ago
Polaryx initiated with a Buy at Maxim
PremiumThe FlyPolaryx initiated with a Buy at Maxim
6M ago
Polaryx selects CRO for Soteria Phase 2 trial
Premium
The Fly
Polaryx selects CRO for Soteria Phase 2 trial
6M ago
Polaryx announces pre-clinical data related to Soteria
Premium
The Fly
Polaryx announces pre-clinical data related to Soteria
6M ago
Polaryx appoints Mitchel Berger, Francis Braun, Charles Ryan to board
PremiumThe FlyPolaryx appoints Mitchel Berger, Francis Braun, Charles Ryan to board
7M ago
Polaryx Therapeutics, Inc. trading resumes
Premium
The Fly
Polaryx Therapeutics, Inc. trading resumes
7M ago
Polaryx Therapeutics, Inc. trading halted, volatility trading pause
Premium
The Fly
Polaryx Therapeutics, Inc. trading halted, volatility trading pause
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100